These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 23320070)

  • 61. Radiotherapeutic bandage based on electrospun polyacrylonitrile containing holmium-166 iron garnet nanoparticles for the treatment of skin cancer.
    Munaweera I; Levesque-Bishop D; Shi Y; Di Pasqua AJ; Balkus KJ
    ACS Appl Mater Interfaces; 2014 Dec; 6(24):22250-6. PubMed ID: 25396281
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Microsphere radioembolization of liver malignancies: current developments.
    Bult W; Vente MA; Zonnenberg BA; Van Het Schip AD; Nijsen JF
    Q J Nucl Med Mol Imaging; 2009 Jun; 53(3):325-35. PubMed ID: 19521312
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Targeting of liver tumour in rats by selective delivery of holmium-166 loaded microspheres: a biodistribution study.
    Nijsen F; Rook D; Brandt C; Meijer R; Dullens H; Zonnenberg B; de Klerk J; van Rijk P; Hennink W; van het Schip F
    Eur J Nucl Med; 2001 Jun; 28(6):743-9. PubMed ID: 11440035
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Radionuclide therapy of skin cancers and Bowen's disease using a specially designed skin patch.
    Lee JD; Park KK; Lee MG; Kim EH; Rhim KJ; Lee JT; Yoo HS; Kim YM; Park KB; Kim JR
    J Nucl Med; 1997 May; 38(5):697-702. PubMed ID: 9170430
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Regional yttrium-90 microsphere treatment of surgically unresectable and chemotherapy-refractory metastatic liver carcinoma.
    Wong CY; Savin M; Sherpa KM; Qing F; Campbell J; Gates VL; Lewandowski RJ; Cheng V; Thie J; Fink-Bennett D; Nagle C; Salem R
    Cancer Biother Radiopharm; 2006 Aug; 21(4):305-13. PubMed ID: 16999596
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Additional holmium-166 radioembolisation after lutetium-177-dotatate in patients with neuroendocrine tumour liver metastases (HEPAR PLuS): a single-centre, single-arm, open-label, phase 2 study.
    Braat AJAT; Bruijnen RCG; van Rooij R; Braat MNGJA; Wessels FJ; van Leeuwaarde RS; van Treijen MJC; de Herder WW; Hofland J; Tesselaar MET; de Jong HWAM; Lam MGEH
    Lancet Oncol; 2020 Apr; 21(4):561-570. PubMed ID: 32112737
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Effect of intratumoral administration on biodistribution of 64Cu-labeled nanoshells.
    Xie H; Goins B; Bao A; Wang ZJ; Phillips WT
    Int J Nanomedicine; 2012; 7():2227-38. PubMed ID: 22619558
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Unresectable lung malignancy: combination therapy with segmental pulmonary arterial chemoembolization with drug-eluting microspheres and radiofrequency ablation in 17 patients.
    Gadaleta CD; Solbiati L; Mattioli V; Rubini G; Fazio V; Goffredo V; Vinciarelli G; Gadaleta-Caldarola G; Canniello E; Armenise F; D'Aluisio L; Gaudiano A; Ranieri G; Goldberg SN
    Radiology; 2013 May; 267(2):627-37. PubMed ID: 23249572
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Role of lipid-soluble complexes in targeted tumor therapy.
    Thakur ML; Coss R; Howell R; Vassileva-Belnikolovska D; Liu J; Rao SP; Spana G; Wachsberger P; Leeper DL
    J Nucl Med; 2003 Aug; 44(8):1293-300. PubMed ID: 12902421
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Radioembolization with infusion of yttrium-90 microspheres into a right inferior phrenic artery with hepatic tumor supply is feasible and safe.
    Burgmans MC; Kao YH; Irani FG; Dames EL; Teo TK; Goh AS; Chow PK; Tay KH; Lo RH
    J Vasc Interv Radiol; 2012 Oct; 23(10):1294-301. PubMed ID: 22922039
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Comparison of positron emission tomography and bremsstrahlung imaging to detect particle distribution in patients undergoing yttrium-90 radioembolization for large hepatocellular carcinomas or associated portal vein thrombosis.
    Padia SA; Alessio A; Kwan SW; Lewis DH; Vaidya S; Minoshima S
    J Vasc Interv Radiol; 2013 Aug; 24(8):1147-53. PubMed ID: 23792126
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Comprehensive Oncologic Imaging in Infants and Preschool Children With Substantially Reduced Radiation Exposure Using Combined Simultaneous ¹⁸F-Fluorodeoxyglucose Positron Emission Tomography/Magnetic Resonance Imaging: A Direct Comparison to ¹⁸F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography.
    Gatidis S; Schmidt H; Gücke B; Bezrukov I; Seitz G; Ebinger M; Reimold M; Pfannenberg CA; Nikolaou K; Schwenzer NF; Schäfer JF
    Invest Radiol; 2016 Jan; 51(1):7-14. PubMed ID: 26309185
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Biodistribution and kinetics of holmium-166-chitosan complex (DW-166HC) in rats and mice.
    Suzuki YS; Momose Y; Higashi N; Shigematsu A; Park KB; Kim YM; Kim JR; Ryu JM
    J Nucl Med; 1998 Dec; 39(12):2161-6. PubMed ID: 9867162
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Holmium-166 poly lactic acid microspheres applicable for intra-arterial radionuclide therapy of hepatic malignancies: effects of preparation and neutron activation techniques.
    Nijsen JF; Zonnenberg BA; Woittiez JR; Rook DW; Swildens-van Woudenberg IA; van Rijk PP; van het Schip AD
    Eur J Nucl Med; 1999 Jul; 26(7):699-704. PubMed ID: 10398817
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Liver tumors: MR imaging of radioactive holmium microspheres--phantom and rabbit study.
    Nijsen JF; Seppenwoolde JH; Havenith T; Bos C; Bakker CJ; van het Schip AD
    Radiology; 2004 May; 231(2):491-9. PubMed ID: 15031432
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Dedicated holmium microsphere administration device for MRI-guided interstitial brain microbrachytherapy.
    de Vries M; Klaassen NJM; Morsink NC; van Nimwegen SA; Nijsen JFW; van den Dobbelsteen JJ
    Med Eng Phys; 2021 Oct; 96():13-21. PubMed ID: 34565548
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Orthotopic pleural mesothelioma in mice: SPECT/CT and MR imaging with HER1- and HER2-targeted radiolabeled antibodies.
    Nayak TK; Bernardo M; Milenic DE; Choyke PL; Brechbiel MW
    Radiology; 2013 Apr; 267(1):173-82. PubMed ID: 23329660
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Percutaneous sclerotherapy of renal cysts with a beta-emitting radionuclide, holmium-166-chitosan complex.
    Kim JH; Lee JT; Kim EK; Won JY; Kim MJ; Lee JD; Hong SJ
    Korean J Radiol; 2004; 5(2):128-33. PubMed ID: 15235238
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Radionuclide liver cancer therapies: from concept to current clinical status.
    Vente MA; Hobbelink MG; van Het Schip AD; Zonnenberg BA; Nijsen JF
    Anticancer Agents Med Chem; 2007 Jul; 7(4):441-59. PubMed ID: 17630919
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Holmium nanoparticles: preparation and in vitro characterization of a new device for radioablation of solid malignancies.
    Bult W; Varkevisser R; Soulimani F; Seevinck PR; de Leeuw H; Bakker CJ; Luijten PR; van Het Schip AD; Hennink WE; Nijsen JF
    Pharm Res; 2010 Oct; 27(10):2205-12. PubMed ID: 20680667
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.